4D Molecular Therapeutics, Inc. (FDMT)
9.72
-0.19
(-1.92%)
USD |
NASDAQ |
Jun 01, 16:00
9.71
-0.01
(-0.10%)
After-Hours: 20:00
4D Molecular Therapeutics Total Liabilities (Quarterly) : 61.07M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 63.33M |
| Agenus, Inc. | 414.44M |
| Amgen, Inc. | 83.31B |
| Anika Therapeutics, Inc. | 45.49M |
| BioCryst Pharmaceuticals, Inc. | 1.019B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 512.90M |
| Shareholders Equity (Quarterly) | 451.84M |
| Debt to Equity Ratio | 0.0454 |
| Current Ratio | 9.339 |
| Net Debt Paydown Yield | 0.17% |